OraSure Technologies Announces 2014 Annual Meeting Date
28 Gennaio 2014 - 12:00PM
OraSure Technologies, Inc. (Nasdaq:OSUR) today announced that its
2014 Annual Meeting of Stockholders is scheduled to be held on
Thursday, May 22, 2014. Further details regarding the meeting will
be provided at a later date.
About OraSure Technologies
OraSure Technologies is a leader in the development, manufacture
and distribution of oral fluid diagnostic and collection devices
and other technologies designed to detect or diagnose critical
medical conditions. Its innovative products include rapid tests for
the detection of antibodies to HIV and HCV at the point of care and
testing solutions for detecting various drugs of abuse. The Company
sells the OraQuick® In-Home HIV Test, the first and only rapid HIV
test approved by the U.S. Food and Drug Administration for sale to
the consumer over-the-counter market in the U.S. In addition, the
Company is a leading provider of oral fluid sample collection,
stabilization and preparation products for molecular diagnostic
applications. OraSure's portfolio of products is sold globally to
various clinical laboratories, hospitals, clinics, community-based
organizations and other public health organizations, research and
academic institutions, distributors, government agencies,
physicians' offices, and commercial and industrial entities. The
Company's products enable healthcare providers to deliver critical
information to patients, empowering them to make decisions to
improve and protect their health.
For more information on the Company, please go to
www.orasure.com.
CONTACT: Company Contact:
Ronald H. Spair
Chief Financial Officer
610-882-1820
Investorinfo@orasure.com
www.orasure.com
Grafico Azioni OraSure Technologies (NASDAQ:OSUR)
Storico
Da Set 2024 a Ott 2024
Grafico Azioni OraSure Technologies (NASDAQ:OSUR)
Storico
Da Ott 2023 a Ott 2024